Related Experiment Video
Updated: Oct 16, 2025

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
Published on: April 18, 2025
circSLC30A7 Inhibits Hepatocellular Carcinoma Cell Proliferation via the miR-767-5p/FBXW7/NOTCH1 Axis
Xiaotian Yu1,2, Yun Zhang2, Chao Jiang2
1Liver Transplantation Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Abstract:
Circular RNAs, noncoding RNAs, have attracted much attention in various human tumor research fields. They regulate the development of various human cancers via microRNA sponges. This study aimed to assess the molecular mechanism of circSLC30A7 in hepatocellular carcinoma (HCC). In our study, we identified that circSLC30A7 was significantly downregulated in HCC cell lines and tissues. Furthermore, gain and loss function experiments were conducted to elucidate the biological functions of circSLC30A7 in HCC cell lines. Mechanistically, circSLC30A7 sponged miR-767-5p, inhibiting the expression of its downstream protein, FBXW7. In summary, this study revealed that circSLC30A7 is an essential tumor suppressor that inhibits HCC tumorigenesis through the miR-767-5p/FBXW7/NOTCH1 axis. Taken together, circSLC30A7 reduces HCC malignancy and can be a biomarker for HCC management.
Insights
Circular RNA SLC30A7 (circSLC30A7) acts as a tumor suppressor in hepatocellular carcinoma (HCC). It inhibits cancer growth by regulating the miR-767-5p/FBXW7/NOTCH1 pathway, suggesting its potential as an HCC biomarker.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Circular RNAs (circRNAs) are noncoding RNAs implicated in human tumor research.
- circRNAs regulate cancer development, often by acting as microRNA sponges.
- Hepatocellular carcinoma (HCC) is a significant global health concern.
Purpose of the Study:
- To investigate the molecular mechanism of circSLC30A7 in hepatocellular carcinoma (HCC).
- To determine the role of circSLC30A7 as a potential tumor suppressor in HCC.
Main Methods:
- Quantitative real-time PCR to assess circRNA expression in HCC cell lines and tissues.
- Gain- and loss-of-function experiments to evaluate the biological impact of circSLC30A7.
- MicroRNA target prediction and validation to elucidate the molecular interactions.
Main Results:
- circSLC30A7 expression was significantly downregulated in HCC cell lines and tissues.
- circSLC30A7 overexpression suppressed HCC cell proliferation and migration.
- circSLC30A7 functioned as a sponge for miR-767-5p, inhibiting FBXW7 expression.
- The miR-767-5p/FBXW7/NOTCH1 axis was identified as the downstream pathway regulated by circSLC30A7.
Conclusions:
- circSLC30A7 acts as a tumor suppressor in HCC by inhibiting tumorigenesis via the miR-767-5p/FBXW7/NOTCH1 axis.
- circSLC30A7 reduces HCC malignancy and holds potential as a diagnostic and prognostic biomarker for HCC management.
Related Concept Videos
MicroRNAs
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Abnormal Proliferation

